(8):
1-8 (2017).
7. Radosinska, J. et al., Panminerva Med. 59(3):
241‐253 (2017).
8. Cheng, Z. et al., Int. J. Mol. Sci. 18(4):
776 (2017).
Notice
We provide information and
expression)
Catalog Number S5564
Storage Temperature –70 °C
Product Description
Human Src N1 is a 59 kDa membrane associated
protein expressed in insect cells by recombinant
baculovirus.
Src is
) is developed in rabbit using a
synthetic peptide (AFEYEDEDGDRITVRSC)
corresponding to amino acids 59-74 of human SKK5
conjugated to KLH as immunogen. Stress activating
protein kinase kinase 5 (SAPKK5
Cancer Res., 60,
47-50 (2000).
4. Minderman, H., et al., Flow cytometric analysis of
breast cancer resistance protein expression and
function. Cytometry, 48, 59-65 (2002).
ES,KAA,PHC 06/06-1
Membrane Type 1 Matrix Metalloproteinase in Human Papillary Thyroid
Carcinomas. Cancer Res. 59: 467-473.
For research use only; not for use as a diagnostic.
Important Note: During
Neuroscience (2004) 24:5258-5268.
58) Okuno, S., et al., Journal of Neuroscience (2004) 24:7879-7887.
59) Karbanova, J., et al., Biomed. Papers (2004) 148:217-220.
60) Wen, Y., et al., J. of Biological
............................. 59
10.6 Enter a new location ............................................................................................................ 59
10.7 Adding More Locations
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 583–789 nmole/min/mg (see
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 583–789 nmole/min/mg (see
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 583–789 nmole/min/mg (see
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 583–789 nmole/min/mg (see
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 583–789 nmole/min/mg (see
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 583–789 nmole/min/mg (see
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 583–789 nmole/min/mg (see
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 583–789 nmole/min/mg (see
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Precautions and Disclaimer
This product is for R&D use only, not for drug,
household
.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: CDK5 ∼59 kDa
p25 ∼49 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 583–789 nmole/min/mg (see